M&G PLC Has $3.64 Million Stock Holdings in Colgate-Palmolive Company $CL

M&G PLC reduced its position in shares of Colgate-Palmolive Company (NYSE:CLFree Report) by 28.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 40,005 shares of the company’s stock after selling 16,185 shares during the quarter. M&G PLC’s holdings in Colgate-Palmolive were worth $3,640,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in CL. Westside Investment Management Inc. increased its position in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the period. Saudi Central Bank bought a new stake in shares of Colgate-Palmolive in the first quarter worth $29,000. Ransom Advisory Ltd bought a new stake in shares of Colgate-Palmolive in the first quarter worth $33,000. Y.D. More Investments Ltd acquired a new stake in Colgate-Palmolive in the first quarter valued at $37,000. Finally, Atticus Wealth Management LLC raised its position in Colgate-Palmolive by 156.8% during the 2nd quarter. Atticus Wealth Management LLC now owns 488 shares of the company’s stock worth $44,000 after purchasing an additional 298 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $78.71 on Friday. The stock has a market capitalization of $63.45 billion, a price-to-earnings ratio of 22.11, a PEG ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The stock’s 50 day moving average price is $79.32 and its two-hundred day moving average price is $85.35.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The company had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 EPS. On average, equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.26%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on CL shares. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. Barclays decreased their target price on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. Evercore ISI dropped their price target on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research report on Monday, November 3rd. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research note on Monday, November 3rd. Finally, Citigroup lowered their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Nine investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $89.87.

Check Out Our Latest Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.